Caprion and HistoGeneX Combine, Creating Global Immune Monitoring & Biomarker Leader

Caprion Biosciences Expands Its Global Biomarker and Immune Monitoring Franchise By Acquiring Serametrix Corporation

Accelerate the clinical development of your immunotherapy

Caprion Biosciences Expands Its Global Biomarker and Immune Monitoring Franchise By Acquiring Serametrix Corporation

Accelerate the clinical development of your immunotherapy

Serametrix provides effective immune monitoring of cancer patients samples to support clinical trials for novel combination and immune-based therapies.

serametrixReveal cancer patient’s immune status

cancerMonitor drug impact on anti-tumor immune response

bloodAdvance cancer therapy through immune monitoring

Latest News

©2019 Serametrix l US: +1-760-652-4060 l Europe: +44 (0)20 8973 3853 | info@serametrix.com